Prognostic factors in prostate cancer: Pathologists glean a wealth of clinical detail from the smallest piece of tissue

British Medical Journal

Volumn 322, Issue 7283, 2001, Pages 378-379

  Montironi, R ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER GRADING; CANCER STAGING; CELL STRUCTURE; EARLY DIAGNOSIS; EDITORIAL; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; ONCOGENE; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RISK FACTOR; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; TUMOR VOLUME;

GENETIC MARKERS; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PLOIDIES; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035901115     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. Prostate cancer: Are new prognostic markers on the horizon?
2. Precursors of prostate cancer, progression, regression and chemoprevention
3. Prostate cancer prevention. Review of target populations, pathological biomarkers and chemopreventive agents
4. Predictive factors in prostate cancer. College of American Pathologists Consensus Statements 1999
5. Prostate tissue factors
6. Divergent neuroendocrine differentiation in prostatic carcinoma
7. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen ablated patients